JAK–STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell States
Laura E. Stevens(Brigham and Women's Hospital), Kornélia Polyák(Dana-Farber Cancer Institute), Jacqueline Salas(Dana-Farber Cancer Institute), Kendell Clement(Broad Institute), Vanessa Almendro(Danaher (United States)), Callahan M. Wilde(Dana-Farber Cancer Institute), Anne Trinh(Brigham and Women's Hospital), Bojana Jovanović(Harvard University), Alexander Meissner(Max Planck Institute for Molecular Genetics), Natalie L. Kingston(Dana-Farber Cancer Institute), Renee C. Geck(Gonzaga University), Nicholas W. Harper(Dana-Farber Cancer Institute), Xintao Qiu(Dana-Farber Cancer Institute), Guillermo Peluffo(Harvard University), Marco Seehawer(Brigham and Women's Hospital), David A. Frank(Brigham and Women's Hospital), Anne Fassl(Harvard University), Maša Alečković(Princeton University), Jacob D. Jaffe(Broad Institute), Daniel Temko(Harvard University), Shawn B. Egri(Broad Institute), Henry W. Long(Dana-Farber Cancer Institute), Ningxuan Zhou(Dana-Farber Cancer Institute), Zheqi Li(Sun Yat-sen University), Piotr Siciński(Harvard University), Sarah R. Walker(Harvard University Press), Beth Overmoyer(Harvard University), Alanna L. Pyke(Dana-Farber Cancer Institute), Alex Toker(Beth Israel Deaconess Medical Center), Shaokun Shu(Peking University), So Yeon Park(Seoul National University Bundang Hospital), Malvina Papanastasiou(Broad Institute)
Cited by 101
Related Papers
Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET
|Nature Medicine|2012|3.7k
Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits
|Nature reviews. Cancer|2009|3.3k